The aim of my project is to create a potent and selective ERAP1 inhibitor using Fragment Based Drug Design approach. This inhibitor will be used for a detailed investigation of ERAP1 functions and its role in inducing AS. This information will allow creating treatment for AS, which currently has no cure.
MChem Chemistry, University of York, 2012
- Laboratory technician, Novartis AG, Basel, Switzerland, 2012-2013 • Intern (placement), F. Hoffmann – La Roche AG, Basel, Switzerland, 2011-2012
- Summer intern, York Structural Biology Laboratory, University of York, 2010
AWARDS AND HONOuRS
Chemistry Department Award, University of York, 2009